Prosecution Insights
Last updated: November 11, 2026

Mesa Biotech Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Mesa Biotech Inc. is active in the Chemistry & Materials technology area with 2 pending office actions. These matters are distributed across 2 distinct examiners and 2 distinct art units. This spread indicates that the patent applications involve different chemical or material classifications requiring specialized review from multiple office divisions. This diversification can be beneficial as it prevents the entire portfolio from being subject to the interpretation of a single examiner or a single art unit's specific policies.

The busiest examiner for the portfolio is KWAK, DEAN P, who is currently handling 1 busiest_examiner_pending action. With 2 pending office actions split between 2 distinct examiners, the company faces a diversified examination environment where each application is being evaluated independently. For a practitioner, this requires a flexible strategy that can adapt to the different technical standards of 2 distinct art units. The presence of multiple examiners means that the overall success is not tied to a single individual's perspective on the chemistry-related innovations, providing a broader base for the company's intellectual property development.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KWAK, DEAN P 1 58.9% +36.7%
MUMMERT, STEPHANIE KANE 1 61.4% +21.2%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18338392 Fluidic Test Cassette KWAK, DEAN P —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17696027 Oscillating Amplification Reaction For Nucleic Acids MUMMERT, STEPHANIE KANE 34d
18338392 Fluidic Test Cassette KWAK, DEAN P —

Top Art Units

Art UnitApps
1798 1
1681 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18338392 Fluidic Test Cassette KWAK, DEAN P 1798 §102§103§112 Final Rejection — Pending Jun 21, 2023
17696027 Oscillating Amplification Reaction For Nucleic Acids MUMMERT, STEPHANIE KANE 1681 §103Other Non-Final OA 34d Pending Mar 16, 2022

Managing Mesa Biotech Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Mesa Biotech Inc. have?

Mesa Biotech Inc. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Mesa Biotech Inc. applications?

Dean P Kwak has the most, with 1 of Mesa Biotech Inc.'s pending office actions.

What technology area are Mesa Biotech Inc.'s patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month